Prospective multicentre study evaluating ctDNA as a biomarker of residual disease after chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: NeckTAR-IN protocol.
- DOI
- 10.1136/bmjopen-2026-118532
- Published
- 2026 Aug 7
- Container
- BMJ open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2026-118532,
title = {Prospective multicentre study evaluating ctDNA as a biomarker of residual disease after chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: NeckTAR-IN protocol.},
author = {Ginzac A and Ventelou L and Ferreira MC and Canetti L and Biau J and Molnar I and Ponelle-Chachuat F and Philippe S and Saroul N and Pham-Dang N and Durando X and Bernadach M},
year = {2026},
journal = {BMJ open},
doi = {10.1136/bmjopen-2026-118532},
url = {https://doi.org/10.1136/bmjopen-2026-118532}
}RIS
TY - JOUR TI - Prospective multicentre study evaluating ctDNA as a biomarker of residual disease after chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: NeckTAR-IN protocol. AU - Ginzac A AU - Ventelou L AU - Ferreira MC AU - Canetti L AU - Biau J AU - Molnar I AU - Ponelle-Chachuat F AU - Philippe S AU - Saroul N AU - Pham-Dang N AU - Durando X AU - Bernadach M PY - 2026 JO - BMJ open DO - 10.1136/bmjopen-2026-118532 UR - https://doi.org/10.1136/bmjopen-2026-118532 ER -
APA
A, G., L, V., MC, F., L, C., J, B., I, M., F, P., S, P., N, S., N, P., X, D., & M, B. (2026). Prospective multicentre study evaluating ctDNA as a biomarker of residual disease after chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: NeckTAR-IN protocol.. BMJ open. https://doi.org/10.1136/bmjopen-2026-118532
Source records
- pubmed · retrieved 2026-09-26T06:49:29.388Z